
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Phreesia reports after market close, meaning Day 0 reflects anticipation before results are released, while Day +1 captures the market's first full reaction to the actual numbers.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-27 | +$0.18 (+2.01%) | $0.32 (3.63%) | +$0.32 (+3.50%) | $1.69 (18.51%) |
| 2026-03-30 | +$0.43 (+3.92%) | $0.45 (4.10%) | -$3.03 (-26.56%) | $1.23 (10.78%) |
| 2025-12-08 | -$0.17 (-0.84%) | $1.84 (9.07%) | -$4.69 (-23.31%) | $3.85 (19.14%) |
| 2025-09-04 | +$0.77 (+2.53%) | $1.51 (4.96%) | -$3.08 (-9.87%) | $2.66 (8.52%) |
| 2025-05-28 | -$1.65 (-6.61%) | $2.19 (8.78%) | +$1.13 (+4.85%) | $1.28 (5.48%) |
| 2025-03-12 | +$0.57 (+2.45%) | $1.29 (5.53%) | +$1.65 (+6.93%) | $2.53 (10.63%) |
| 2024-12-09 | -$0.10 (-0.46%) | $0.89 (4.10%) | +$2.51 (+11.60%) | $3.44 (15.93%) |
| 2024-09-04 | +$0.37 (+1.55%) | $1.68 (7.08%) | +$1.52 (+6.29%) | $3.43 (14.21%) |
| Avg Abs Move | 2.55% | 5.91% | 11.61% | 12.90% |
Historical price action around earnings shows significant volatility, with an average absolute Day +1 move of 11.61% and intraday range of 12.90%. The most dramatic reactions occurred in December 2025 (-23% Day +1) and March 2026 (-27% Day +1), both following quarters where the company beat estimates but likely disappointed on guidance or forward commentary.
More recently, volatility has moderated. The May 2026 report produced a +4% Day +1 move with an 18.51% intraday range, while March 2026's initial +4% Day 0 pop reversed sharply the next session. The pattern suggests investors should brace for double-digit percentage swings regardless of whether the company beats or misses — execution and guidance matter more than the headline number.
Day 0 moves average just 2.55%, indicating limited pre-announcement drift, while the 5.91% average Day 0 range shows modest anticipation volatility before results drop.
| Metric | Value |
|---|---|
| Expiration Date | 09/18/26 (DTE 17) |
| Expected Move | $1.66 (14.00%) |
| Expected Range | $10.18 to $13.50 |
| Implied Volatility | 86.38% |
The options market is pricing a 14.00% expected move through the September 18 expiration, implying a range of $10.18 to $13.50. This sits above the 11.61% average historical Day +1 move but below the 12.90% average intraday range, suggesting options traders are pricing in elevated but not extreme volatility relative to recent history.
Analyst sentiment on Phreesia reflects measured optimism. The consensus rating stands at 3.95 out of 5.0 — solidly in buy territory but not overwhelmingly bullish. The breakdown shows 8 Strong Buys, 3 Moderate Buys, 9 Holds, and zero Sells, indicating a split between believers in the turnaround story and those waiting for more proof.
The average price target of $13.94 implies 17.7% upside from the current price of $11.84, with estimates ranging from a low of $9.00 to a high of $20.00. This wide dispersion reflects uncertainty about the sustainability of recent profitability gains and the company's long-term margin profile.
Sentiment has remained unchanged over the past month, with the same rating distribution and average recommendation. This stability suggests analysts are in wait-and-see mode ahead of earnings, with no major upgrades or downgrades recently. The lack of movement indicates the Street is comfortable with current expectations but not compelled to chase the stock higher until the company proves it can sustain momentum.
The Barchart Technical Opinion rates PHR as a Buy with a 24% signal, unchanged from last week but up from 8% a month ago. This improvement reflects growing technical momentum as the stock has climbed from the low $10s into the mid-$11s over the past several weeks.
Timeframe Analysis:
Trend Characteristics: The Weak strength and Weakest direction classification suggests the technical setup lacks conviction heading into earnings, with the stock vulnerable to sharp moves in either direction depending on results.
PHR currently trades at $11.84, positioned below its 5-day ($11.93), 10-day ($11.90), 20-day ($11.96), and 200-day ($12.45) moving averages, but above its 50-day ($11.12) and 100-day ($10.21) averages. This mixed picture — above intermediate support but below short-term and long-term resistance — suggests the stock is caught in a consolidation zone.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $11.93 | 50-Day MA | $11.12 |
| 10-Day MA | $11.90 | 100-Day MA | $10.21 |
| 20-Day MA | $11.96 | 200-Day MA | $12.45 |
Key resistance sits at the 20-day moving average of $11.96 and the psychologically important $12.00 level, with the 200-day at $12.45 representing a more significant hurdle. Support lies at the 50-day moving average of $11.12, with the 100-day at $10.21 providing a secondary floor. The overall technical setup is neutral to cautiously constructive — the stock has built a base above its intermediate moving averages, but lacks the momentum to break through overhead resistance without a catalyst. Earnings could provide that spark, but the weak trend characteristics suggest investors should expect volatility rather than a clean directional move.